Notícias · Recifes

Psychedelics not yet ready for clinical use in ADHD treatment, study finds

In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD. The internet is full of personal accounts describing improved concentration, better impulse control and enhanced well-being.

Admin Recifes 15/07/2026 1

Could creatine help depression? What five clinical trials show so far

Could the same supplement many people take to build muscle also help treat depression? O recorte ajuda a contextualizar a pauta dentro de Fitness.

Admin Recifes 15/07/2026 1

New biological clues behind coffee's benefit to liver health

In one of the most comprehensive studies of coffee and liver health to date, Cedars-Sinai Health Sciences University investigators linked higher coffee consumption with a lower risk of cirrhosis, liver cancer and liver-related death. The findings, published in Clinical Gastroente

Admin Recifes 15/07/2026 1

Common mucus-clearing treatments don't help ICU patients breathe easier and may cause harm

For patients struggling to breathe because of acute respiratory failure, clearing mucus from the airways is a routine part of treatment. Mucoactive agents are widely used for this purpose. But after years of clinical use, one question remains: Do mucoactive agents actually help?

Admin Recifes 15/07/2026 1

Parkinson's patients undergoing deep brain stimulation show little to no cortical Lewy pat

Researchers at the Icahn School of Medicine at Mount Sinai have found that patients with Parkinson's disease undergoing deep brain stimulation (DBS) show little to no Lewy pathology in the prefrontal cortex at the time of their DBS surgery, despite often having longstanding, clin

Admin Recifes 15/07/2026 1

'Polypill' for heart failure cuts hospitalizations and ER visits by 60% in trial

A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more effective for patients than taking the drugs separately, a randomized clinical trial led by UT Southwestern Medical Center researchers showed. The findings, publis

Admin Recifes 15/07/2026 1

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a k

Admin Recifes 15/07/2026 1

Brain tumor vaccine links mutation targeting to eight-year survival gains

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions

Admin Recifes 15/07/2026 1

AI tool can identify biological profiles associated with thrombosis risk

Two people may be the same age and have similar family histories or risk factors, yet only one of them may develop thrombosis. To better understand why this occurs, researchers from the Complex Disease Genomics Unit at the Sant Pau Research Institute (IR Sant Pau) and the Biomedi

Admin Recifes 15/07/2026 1

Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NET

Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy

Admin Recifes 15/07/2026 1

Using AI to provide new insights into why Ebola outcomes differ between patients

There is currently a serious outbreak in the Democratic Republic of the Congo of the severe and often fatal illness. Symptoms include fever, vomiting, diarrhea, severe dehydration and hemorrhage. Rapid clinical deterioration is common. University of Liverpool researchers have led

Admin Recifes 15/07/2026 1

Drug candidate treats severe fatty liver disease by protecting the gut in animal models

Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.

Admin Recifes 15/07/2026 1

Acompanhe as Notícias da Recifes